All Stories

Takeda fronts $46M for 2nd small molecule collab with BridGene

Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology.

Feb 25, 2025 - 14:11
 0
Takeda fronts $46M for 2nd small molecule collab with BridGene
Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology.
Read More

Tags:

Previous Article

Repare unveils scale of layoffs with 75% of staff and chief medical officer head...

Next Article

‘Fear and uncertainty’: Biotech investors warn of impact from NIH research cuts

Related Posts

Roche rolls out new DNA 'sequencing-by-expansion' approach

Roche rolls out new DNA 'sequencing-by-expansion' approach

Feb 21, 2025  0

UPDATE: Judge temporarily blocks NIH grant changes in 22 states

UPDATE: Judge temporarily blocks NIH grant changes in 2...

Feb 11, 2025  0

Ascletis' swift surge into obesity continues with competitive oral GLP-1 data

Ascletis' swift surge into obesity continues with compe...

Feb 19, 2025  0